in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance. .
former novartis exec to lead cambridge diabetes startup semma .
treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk. . .